{"schema_version":"secwatch.filing_event.v1","accession":"0001035267-22-000006","form_type":"8-K","ticker":"ISRG","cik":"0001035267","company_name":"INTUITIVE SURGICAL INC","filed_at":"2022-01-20T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.184459+00:00","generated_at":"2026-06-27T16:42:40.685695+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Intuitive Q4 revenue $1.55B (+17% YoY); da Vinci procedures +19%; GAAP EPS $1.04, non-GAAP $1.30","bullets":["GAAP net income $381M ($1.04/diluted share); non-GAAP net income $477M ($1.30/diluted share).","Worldwide da Vinci procedures increased ~19% vs Q4 2020; CAGR vs Q4 2019 was ~13%.","Shipped 385 systems (+18% YoY); installed base reached 6,730 systems (+12% YoY).","Instruments & accessories rev $843M (+13%); systems rev $470M (+28%); cash & investments $8.6B.","Q4 2021 COVID-19 resurgence impacted procedures; 2020 Q4 also disrupted by pandemic."],"urls":{"canonical":"https://secwatch.observer/filing/0001035267-22-000006","json":"https://secwatch.observer/filing/0001035267-22-000006.json","markdown":"https://secwatch.observer/filing/0001035267-22-000006.md","text":"https://secwatch.observer/filing/0001035267-22-000006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1035267/000103526722000006/0001035267-22-000006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1035267/000103526722000006/isrg-20220120.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T16:42:40.685695+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}